Posts Tagged ‘DEA’
Former Drug Warriors Say Marijuana is Dangerous in Order to Get Rich
By Kevin Gray
When eight former DEA chiefs signed a letter to US Attorney General Eric Holder earlier this month, demanding that the feds crack down on Washington and Colorado, the states which voted last November to legalize marijuana, there was more than just drug-war ideology at stake. There was money.
Two of the elder drug warriors, Peter Bensinger (DEA chief, 1976–1981) and Robert DuPont (White House drug chief, 1973–1977), run a corporate drug-testing business. Their employee-assistance company, Bensinger, DuPont & Associates, the sixth largest in the nation, holds the pee stick for some 10 million employees around the US. Their clients have included the biggest players in industry and government: Kraft Foods, American Airlines, Johnson & Johnson, the Federal Aviation Administration and even the Justice Department itself.
“These are not just old drug war architects pushing a drug war model they’ve pushed for 40 years,” says Brian Vicente, a Denver lawyer and co-author of Colorado’s Proposition 64, which legalized marijuana for recreational use. “These guys are asking Eric Holder to pursue prohibition policies that line their own pockets.”
Bensinger and DuPont both deny money is their motive. “It’s true we might benefit from keeping marijuana illegal,” says DuPont. But he argues it’s equally true that marijuana legalization could benefit his bottom line, putting forth the old drug-war line that legalization would create more users.
“The more success legalization has, the better it is for our business because they are creating a problem for employers,” he says. “That would be smart for us.” DuPont also points out that only 15% of their business is made up of training employers to detect the warning signs of drug and alcohol abuse and supplying third-party testing. But both men are involved in industry-controlled lobbying groups like the Drug & Alcohol Industry Testing Association, which backed the Drug Testing Integrity Act of 2008, outlawing products that help people beat drug tests and keeping their business healthy.
By inserting themselves into the legal-pot debate, Bensinger, DuPont and other drug warriors benefit by promoting their own legacies and bolstering their own business, lobbying and consulting interests—even in the face of an increasingly skeptical public. A 2011 Gallup survey showed that half of Americans favor legalizing weed. “This letter that they signed is their attempt to once again become relevant within the public policy debate that has largely turned its back on such archaic viewpoints,” says Paul Armentano, deputy director of the pro-marijuana nonprofit, National Organization for the Reform of Marijuana Laws (NORML).
The time-honored revolving door between government and business swings fast and often. It can be straightforward, like the appointment of banking behemoth Goldman Sachs’ alumni as economic policymakers by recent presidential administrations. But when it comes to the drug war, the family tree is more like a thicket of interests among law enforcement, federal and state prisons, pharmaceutical giants, drug testers and drug treatment programs—all with an economic stake in keeping pot illegal.
Bensinger and DuPont are longtime allies of the marijuana prohibition group that sent the letter to Holder, Save Our Society from Drugs (SOS), which was founded by Mel Sembler, a Florida shopping-mall magnate, and his wife, Betty. The Semblers also founded Straight Inc.—a drug-treatment program that used sleep deprivation, beatings and psychological abuse to treat 10,000 teenage patients, in nine states, from 1976 to 1993, at $1,400 a month plus a $1,600 per patient evaluation fee, raking in millions. Straight wasshut down after investigations in state after state corroborated the hundreds of complaints. But the Semblers, longtime major Republican Party fundraisers, retain their influence as behind-the-scenes bankrollers of the anti-drug faction.
The department of the White House drug czar, otherwise known as the Office of National Drug Control Policy (ONDCP), is another arm of the government’s war on drugs that can be lucrative to incumbents. Andrea Barthwell, MD, former deputy drug czar during President George W. Bush’s first term and his point person against medical marijuana, has earned a living both treating drug addicts and lobbying against policies that weaken marijuana laws—and cut into her own bottom line.
As a past president of the American Society of Addiction Medicine (ASAM)—a group that opposes medical marijuana, and whose members’ business model could be threatened by legalized marijuana, since two-thirds of its clientele are court-ordered pot users trying to avoid jail time—Barthwell has been one of its fiercest attack dogs. In ASAM campaigns against Oregon and Illinois’ medical marijuana initiatives, she called those who favor medical marijuana “cruel” and “snake oil salesman.” She denounces this pain-relief and anti-nausea approach for patients with cancer and AIDS because, she claims, it is unregulated and unproven (the Institute of Medicine declared medical marijuana useful in 2003, and since then many studies, and many more users, attest to its benefits.)
Yet Barthwell was happy to jump from the ONDCP to the payroll of GW Pharmaceutical in 2005, lobbying for the Canadian company’s Sativex—a liquefied marijuana spray, extracted from whole plant cannabis, for the same pain benefits. Even as the American Medical Association and federal lawmakers maintain that pot has no medicinal value, Big Pharma is applying for dozens of cannabis-based new medicines in order to take hold of of the $1.8 billion medical marijuana industry, as NORML’s Paul Armentano pointed out five years ago in the Huffington Post.
Barthwell, like Bensinger and DuPoint, also has a financial stake in the prohibition treatment culture. She is founder and CEO of EMGlobal LLC, parent company of the Chicago-based Two Dreams Outer Banks drug treatment center, and is also a director of Catasys Inc., which provides substance abuse programs and behavioral health management services to companies, health plans and unions—a role for which she received $77,994 in compensation in 2011.
When it comes to the drug war, money rolls into whichever corporate pockets are willing to play ball, whether it’s big-time lobbyists or broadcast TV networks. Barry McCaffrey—President Clinton’s second-term drug czar and a former Army general, who also signed the recent letter to Holder—was in charge of the purse strings at ONDCP. He oversaw a money-soaked, ham-handed propaganda campaign: In 1999, his office hired PR giant Fleishman-Hillard (at $10 million a year), which encouraged TV networks to slip anti-drug messages into sitcoms and dramas in exchange for ad time worth millions. The secret effort allowed networks to avoid running PSAs, freeing up airtime for paid ads. Networks also gave the ONCDP advance copies of scripts to review. It’s estimated that between 1998 and 2000, the networks received up to $25 million in benefits.
At the same time, McCaffrey was sharpening his stick for the battle against medical marijuana, flatly denying that patients in pain could receive relief from pot. After he left the drug czar’s job, he went on the payroll of military contractors, promoting their interests in the Iraq war as a frequent talking head on national network TV, never disclosing his financial ties.
Lobbying your former employer—whether it’s the government itself or taxpayers who foot the bill—is the No. 1 way one-time public servants can serve themselves. The same is true of current state-paid employees, like cops and other law enforcement personnel whose job it is to crack down on illegal weed smoking. As Armentano notes, federal grants that target illegal drug use are a major source of funding for local police coffers, paying for new hires, equipment and coveted overtime pay.
John Lovell, a lobbyist for police associations in Sacramento, California, not only obtains those grants, he is a front-line fighter on behalf of the cops to keep pot illegal. When California weighed Proposition 19 to legalize marijuana in 2010, Lovell helped manage the opposition campaign. During the fight, according to a reviewof lobbying contracts by Republic Report, Lovell’s company received $386,350 from police groups, including the California Police Chiefs Association. The same report noted that Lovell helped local police departments apply for drug war money from President Obama’s American Recovery and Reinvestment Act. In 2009 and 2010, state police groups sought some $75 million from the feds to conduct a Campaign Against Marijuana Planting. Lovell represented one such group.
Indeed, law enforcement agencies around the country could lose as much as $11 billion in taxpayer money if marijuana prohibition is repealed, according to Harvard economics professor Jeff Myron. Weed arrests account for half of all drugs arrests in the US. The tangled money trail can seem at times like something from a smoke-filled Cheech and Chong plot.
In 2009, the California Police Chiefs Association posted on their website a position paperagainst pot for pain, courtesy of a group called Friends of the DEA. “Requiring the DEA unequivocally to take a ‘hands-off’ approach, no matter how egregious the dispensary’s practices, will not serve the best interests of patients. Uncontrolled proliferation of dispensaries will seriously undercut our FDA drug approval system and deprive patients of important regulatory protections,” the group argued. What the paper didn’t note was that Friends was a lobbying group headed by Michael Barnes, a former Bush appointee to the drug czar’s office, as first pointed out by CounterPunch that year. The nine-page, heavily footnoted position paper was written by none other than Andrea Barthwell, MD, the promoter of Sativex, which is likely to receive FDA approval soon.
Among the biggest financial winners from the war on pot are private prisons and the army of DEA agents, local deputies and SWAT teams who help fill them up. Since 1980, federal prisons have ballooned some 790% because of the war on drugs, which began in earnest the previous decade. Private prison companies have seen their business soar. Corrections Corporation of America (CAA), the largest operator in the US, with 60 facilities and a 90,000-bed capacity, had $1.7 billion in tax-payer-funded revenue last year. The GEO Group, a worldwide player with 53,000 beds, pulled in $1.6 billion in government-funneled revenue.
In its 2010 annual report, CAA is fairly transparent about its stake in the anti-drug battle: “Any changes [in laws] with respect to drugs and controlled substances or illegal immigration could affect the number of persons arrested, convicted and sentenced, thereby potentially reducing demand for correctional facilities to house them.” Last year, both companies stuffed millions of dollars into the pockets of Washington lobbyists to pressure lawmakers to maintain the status quo, as revealed in an investigation by Laura Carlsen in March’s Counter Punch magazine.
“My most powerful adversity is the police-prison industry,” says former cop–turned–drug policy specialist Howard Woolridge, who lobbies lawmakers for marijuana reform for Citizens Opposing Prohibition. “They can say, ‘If you don’t vote for more prohibition, we will tell people you are soft on drugs on and soft on crime.’ The Fraternal Order of Police is looking out for their 326,000 members’ paychecks. If they say you’re soft on crime, they can move upward of 2% of the electorate. In a close election, that’s victory and defeat.”
Vincente doesn’t doubt that the Bensingers, Bathwells and McCaffreys are fervent believers in their anti-pot mission, even as they earn their living on its front lines or flanks. The same people who wrote to Holder battled Vincente’s initiative as well. “It’s what they do—they get together and sign letters,” he says. For the older fighters, says Paul Armentano of NORML, “Their motivation is the fact their failed polices have been proved wrong. All they have is the ability to try to intimidate a couple of high-ranking officials. Most of America has moved on.”
Attorney General Eric Holder may recognize this. He has told members of the Senate that the Obama administration is still formulating its policy toward the states that legalized pot. “We are considering what the federal response to those new statutes will be,” Holder said at a Senate Judiciary Committee hearing this week. “We will have the ability to announce what our policy will be relatively soon.”
So far he has not answered the drug warriors’ letter.
Source: http://www.thedailychronic.net/2013/16605/former-drug-warriors-say-marijuana-is-dangerous-in-order-to-get-rich/
Take Action to End Marijuana Prohibition!
by Erik Altieri
Last month, Congressman Jared Polis (D-CO) introduced legislation, House Resolution 499, which would effectively end the federal prohibition on marijuana and allow states to set their own policies.
House Resolution 499: The Ending Marijuana Prohibition Act of 2013, would remove marijuana from the Controlled Substances Act, transfer the Drug Enforcement Administration’s authority to regulate marijuana to a newly renamed Bureau of Alcohol, Tobacco, Marijuana and Firearms, require commercial marijuana producers to purchase a permit, and ensure that federal law distinguishes between individuals who grow marijuana for personal use and those involved in commercial sale and distribution.
You can read the full text of this measure here.
Congress needs to hear from you, please take a minute and click here to quickly and easily write your Representative and urge him or her to support the Ending Federal Marijuana Prohibition Act of 2013!
CLICK HERE TO WRITE YOUR REPRESENTATIVE
Court Rejects Challenge To The Prohibitive Classification Of Cannabis
Washington, DC: A three-judge panel for the US Court of Appeals for the District of Columbia last week denied petitioners request to overturn the Obama administration’s July 2011 rejection of an administrative petition that sought to initiate hearings regarding the reclassification of marijuana under federal law.
Petitioners sought a hearing regarding whether existing science contradicts the federal categorization of cannabis as a Schedule I controlled substance that possesses “a high potential for abuse;” “no currently accepted medical use in treatment;” and “a lack of accepted safety for the use of the drug … under medical supervision.” The Court affirmed the position of the US Drug Enforcement Administration that, at this time, insufficient clinical studies exist to warrant a judicial review of cannabis’ federally prohibited status.
Petitioners are expected to appeal the decision.
For more information, please visit: http://safeaccessnow.org. Full text of the decision, Americans for Safe Access et al. v. Drug Enforcement Administration, is available online here: http://americansforsafeaccess.org/downloads/CRC_Appeal.pdf.
Federal Court of Appeals Denies Petition to Reschedule Marijuana
by Erik Altieri
In a 28-page decision, the US Court of Appeals for the District of Columbia Circuit has denied petitioners request to overturn the July 2011 denial by the Drug Enforcement Administration to initiate proceedings to reschedule marijuana under federal law.
In October 2002, the Coalition to Reschedule Cannabis, a coalition of reform organizations including NORML, ASA, Patients Out of Time and High Times, among others, petitioned the DEA to reschedule marijuana as a Schedule III, IV, or V drug. Following years of administrative delay, on July 8, 2011, the DEA denied the petition, finding that “[t]here is no currently accepted medical use for marijuana in the United States,” and that “[t]he limited existing clinical evidence is not adequate to warrant rescheduling of marijuana under the CSA.”
Petitioners then sought review in the federal Court of Appeals, alleging the decision by the DEA was arbitrary and capricious when it concluded that marijuana lacks a “currently accepted medical use” and has a “high potential for abuse.” They ask this court to remand the case to the DEA for reconsideration of its decision.
Written by Senior Circuit Judge Edwards, the decision ruled “On the record before us, we hold that the DEA’s denial of the rescheduling petition survives review under the deferential arbitrary and capricious standard. The petition asks the DEA to reclassify marijuana as a Schedule III, IV, or V drug, which, under the terms of the CSA, requires a ‘currently accepted medical use.’ The DEA’s regulations, which we approved in Alliance for Cannabis Therapeutics v. DEA, 15 F.3d 1131 (D.C. Cir. 1994), define ‘currently accepted medical use’ to require, inter alia, ‘adequate and well-controlled studies proving efficacy.’ Id. at1135. We defer to the agency’s interpretation of these regulations and find that substantial evidence supports its determination that such studies do not exist.
“In its scientific and medical evaluation,” the court held, “DHHS concluded that marijuana lacks a currently accepted medical use in the United States. In reaching this conclusion, DHHS applied the DEA’s established five-prong test, which requires a known and reproducible drug chemistry, adequate safety studies, adequate and well-controlled studies demonstrating efficacy, acceptance of the drug by qualified experts, and widely available scientific evidence.”
“We will not disturb the decision of an agency that has ‘examine[d] the relevant data and articulate[d] a satisfactory explanation for its action including a rational connection between the facts found and the choice made.’”
In this case, we need only look at one factor, the existence of “adequate and well-controlled studies proving efficacy,” to resolve Petitioners’ claim.
At bottom, the parties’ dispute in this case turns on the agency’s interpretation of its own regulations. Petitioners construe “adequate and well-controlled studies” to mean peer-reviewed, published studies suggesting marijuana’s medical efficacy. The DEA, in contrast, interprets that factor to require something more scientifically rigorous.
In making this assessment, we must “remind ourselves that our role in the Congressional scheme is not to give an independent judgment of our own, but rather to determine whether the expert agency entrusted with regulatory responsibility has taken an irrational or arbitrary view of the evidence assembled before it.
The DEA’s construction of its regulation is eminently reasonable. Therefore, we are obliged to defer to the agency’s interpretation of “adequate and well-controlled studies.” Judged against the DEA’s standard, we find nothing in the record that could move us to conclude that the agency failed to prove by substantial evidence that such studies confirming marijuana’s medical efficacy do not exist.”
Petitioners are considering their legal options at this time.
Even in pot-friendly states, selling is risky business

Take California. While the state has had medical marijuana dispensaries for more than 15 years, it remains a target for federal law enforcement officials, where the U.S. Drug Enforcement Administration arrested nearly 8,500 people for marijuana-related offenses between 2004 and 2010.
California’s hardly alone. Several other states with dispensaries have seen an increase in both arrests and the confiscation of marijuana plants. However, a look at DEA records shows what appears to be an uneven enforcement policy among pot-friendly states over the past several years.
For example, while arrests and eradication in California climbed fairly steadily in the seven-year time frame, they remained essentially flat in Maine. Colorado, meanwhile, saw a reversal in both trends halfway through the time period.
Americans for Safe Access, which advocates the legalization of medical marijuana, says the Justice Department has conducted nearly 200 raids on dispensaries and growers since President Barack Obama took office.
“The assault on medical marijuana patients currently under way by the Obama administration is unprecedented in this country’s history,” said Steph Sherer, the organization’s founder and executive director. “The intensity and breadth of the attacks has far surpassed anything we saw under the Bush administration and has resulted in the roll-back of numerous local and state laws, not just in California.”
The government’s focus on the industry has taken many lawmakers and medical marijuana activists by surprise. During his presidential campaign four years ago, Obama vowed to maintain a hands-off approach toward pot clinics and dispensaries that adhere to state law.
Perhaps not surprisingly, California, which legalized marijuana in 1996 and has long been considered a hub for the pot community, has been the state most targeted by federal officials. In 2004, the DEA made 869 marijuana-related arrests, seizing 1.2 million plants that were cultivated to produce marijuana buds. Both numbers climbed steadily through 2009, according to statistics provided by the DEA, peaking at 1,738 arrests and 7.5 million plants. (In 2010, the numbers slipped slightly to 1,591 arrests and 7.4 million plants.)
California and federal officials have been at odds for years over medical marijuana, since the Controlled Substances Act still classifies the drug as illegal. Federal prosecutors have frequently targeted dispensaries that make profits, noting California law requires those facilities to run as not-for-profit collectives. Those dispensaries, though, are often significant sources of tax income.
Michigan may not boast the hard arrest and confiscation numbers that California does, but federal officials have been even more active there since medical marijuana was legalized in 2008. Arrests have climbed 223 percent since legalization (from 290 in 2007 to 647 in 2010). Plant seizures have increased by 68 percent in that time, according to the DEA.
Similarly, Montana, which legalized medical usage in 2004, saw a slight increase in arrests (with the biggest spike coming the year dispensaries opened) between 2004 and 2010. Last year, though, federal officials executed a series of raids that largely shut down pot providers in the state.
Since New Mexico legalized medicinal marijuana in 2007, however, arrests (which were never noteworthy to begin with) have dropped — from 16 in 2006 to just 4 in 2010 — while confiscations have generally fallen over the years, but spiked in 2010, with more than 8,400 plants destroyed.
It’s worth noting that these DEA statistics, while interesting, do not paint a complete picture. The agency focuses on big targets and distributors (including growers who work within the boundaries of the state law as well as those who do not). Its numbers do not include individuals who are arrested on possession charges, something that’s largely done on a city and county basis.
DEA officials play down the numbers, noting there are intangible factors that cause them to fluctuate each year.
“It’s difficult to draw conclusions based on the superficial data you’re looking at,” says Todd Scott, an agent who has worked with the DEA for 17 years. “What prompts a raid on [a dispensary] is a whole host of factors. I think there’s a misconception that a particular raid is a medical marijuana raid. If you find a grow, you don’t often know prior to that that it’s a ‘medical marijuana grow’.”
The reasons for the raids vary, as they do with any criminal investigation. There are some red flags, though. For instance, if a dispensary is suspected of illegally trafficking pot to people without prescriptions, that could attract federal attention. If a grow operation is of a substantial size (with tens of thousands of plants), that too can turn heads (since it’s such a flagrant violation of the Controlled Substances Act). Growers and dispensaries, though, say there has not been an obvious pattern to recent raids.
Nowhere is the fluctuation more in evidence than Colorado, where medicinal pot has been legal since 2000. From 2004 to 2007, arrests and eradications varied somewhat, but not wildly. They peaked at 341 in that period, while the DEA destroyed between 5,000 and 7,500 plants per year. In 2008, though, things changed considerably.
Plant eradications skyrocketed to over 30,000, while arrests fell to just 36. The numbers ebbed and flowed a bit more in the following two years, but arrests remained low, while more plants were destroyed.
Meanwhile, in Rhode Island (which legalized the drug for medicinal purposes in 2006), the threat of raids and employee prosecution from the U.S. Attorney’s office has kept dispensaries from opening. But looking at the DEA’s arrest record, no one seems to be taking much notice of the pot trade in the state. Through 2010, federal officials had only made nine arrests — and destroyed just 16 plants.
The DEA notes that cases tend to roll from one to another. An arrest in one incident can lead to tips about other illegal activity, which can explain the discrepancies. And since federal officials focus their efforts on larger busts, some operations might be too small to capture their attention.
“We are a proactive agency,” says Scott. “We don’t have to wait for a bank to get robbed or a car to get stolen to launch an investigation. As a federal agent, is it a productive use of my time to investigate a guy with five plants? Probably not. Is it worth my time for a guy who’s growing 500 plants? Well, probably so. But is there a number [that constitutes a cut-off point]? No.”
This article, “Risky business, even in pot-friendly states,” first appeared on CNBC.com.
DEA digging into San Francisco’s medical marijuana dispensaries
Special To The SF Examiner
The federal Drug Enforcement Administration has asked The City’s Department of Public Health to turn over records for 12 of San Francisco’s remaining 21 medical cannabis dispensaries, according to emails obtained by The San Francisco Examiner.
On Jan. 18 and again Jan. 27, Special Agent David White of the DEA’s financial investigative team sent emails to the health department asking for business licenses, health permits, ownership information and yearly inspection forms for the 12 dispensaries.
Last year, White requested information on five other San Francisco dispensaries, issuing a subpoena to obtain private information not normally released via a records request. The landlords of those dispensaries then received letters from U.S. Attorney Melinda Haag, who warned of property forfeiture and 40-year prison terms unless the dispensaries shut down.
All five dispensaries closed, though two have since become delivery-only services.
Health department Deputy Director Colleen Chawla said her agency complied with the DEA’s most recent request.
White did not respond to a request for comment. Agent Casey McEnry, a DEA spokeswoman, said the agency only comments on cases actively in the courts.
On Oct. 7, the four U.S. attorneys for California announced a coordinated, statewide crackdown on what they called the “medical marijuana industry.” Since then, hundreds of dispensaries have closed, mostly in Sacramento and San Diego counties. Five have closed in San Francisco, and one in Marin.
Stephanie Tucker, a spokeswoman for The City’s Medical Cannabis Task Force, is concerned by the prospect of 12 more dispensaries closing.
“It’s a clear indication that Melinda Haag is not using the discretion of her office to go after bad players as stated at her October 2011 press conference,” Tucker told The SF Examiner on Thursday. “Instead, they are targeting the regulated community who operate with a permit, in compliance with state and local laws, transparently and in good standing with The City and their community.”
Medical marijuana advocates also are rankled by what they call inaction taken by city leaders.
In 2008, then-Mayor Gavin Newsom sent a letter to members of Congress asking them to intervene in the DEA’s “undermin[ing] of California’s state medical marijuana laws.” Newsom’s successor, Mayor Edwin Lee, has yet to comment on the crackdown publicly, and on Thursday he did not respond to requests for comment on the health department emails.
The Board of Supervisors passed a resolution in support of dispensaries in the fall, but has not taken action since.
“There’s a definite void in leadership here,” Assemblyman Tom Ammiano, D-San Francisco, told The SF Examiner on Thursday, adding that federal law enforcement is “undermining the will of the voters” encapsulated in Proposition 215, which legalized marijuana for medicinal use when it passed in 1996.
“I understand this is a radioactive issue for some people, but too bad — it’s the law of the land,” Ammiano said.
There were 26 dispensaries in San Francisco in October. After The City briefly suspended its permitting process, the Planning Commission is scheduled to hear applications for two new dispensaries at its meeting next week.
San Francisco was the first city in California to license and regulate medical marijuana dispensaries under its Medical Cannabis Act, which became law in 2005. Much of The City’s regulations are stricter than what is allowed under state law.
Dispensaries pay local and state sales taxes. The health department inspects them once a year to ensure that they comply with city and state laws. All of San Francisco’s dispensaries were found to be in compliance during the most recent inspections.
Open and shut
Last month, the DEA asked city officials for information on 12 of San Francisco’s remaining 21 medical cannabis dispensaries. They are:
Good Fellows Smoke Shop, 473 Haight St.
Re-Leaf Herbal Center, 1284 Mission St.
The Green Cross, 1230 Market St.
Grass Roots, 1077 Post St.
Emmalyn’s, 1597-A Howard St.
Bay Area Safe Alternatives Collective, 1326 Grove St.
SF Medical Cannabis Club, 120 10th St.
Waterfall Wellness, 1545 Ocean Ave.
Hope Net, 223 Ninth St.
Valencia Street Caregivers, 208 Valencia St.
Vapor Room, 607A Haight St.
Shambala Healing Center, 2441 Mission St.
Last year, the DEA made similar requests for information on five other dispensaries. Those dispensaries then closed after receiving threatening letters from U.S. Attorney Melinda Haag. Those dispensaries were:
Mr Nice Guy, 174 Valencia St.
Divinity Tree Wellness Co-op, 958 Geary St.
Medithrive, 1933 Mission St.
Market Street Collective, 1884 Market St.
Sanctuary, 669 O’Farrell St.
Read more at the San Francisco Examiner: http://www.sfexaminer.com/local/2012/02/dea-digging-san-franciscos-medical-marijuana-dispensaries#ixzz1mI6WGKM3
Struggling Cities Turn to a Crop for Cash
By MICHAEL COOPER
Published: February 11, 2012
OAKLAND, Calif. — As the stubborn economic downturn has forced this city to take painful steps to balance its budget in recent years, it has increasingly turned to one of its newer industries to raise much-needed revenues: medical marijuana dispensaries.
The city has raised taxes on marijuana dispensaries several times in the past few years, and last year it collected $1.4 million in taxes from them — nearly 3 percent of all the business taxes it collected. Now Oakland plans to double the number of dispensaries it licenses, to eight from the current four, in the hopes that it can collect even more revenue.
“This is general fund revenue — it all goes into the melting pot,” said David McPherson, the city’s tax and revenue administrator. “When you’re making decisions about what to continue keeping or not, it goes into that decision process. If you don’t have that money, then you’re making other decisions about ‘Are we going to close the libraries on Monday?’ ‘Are you going to end up cutting a cop?’ ‘Are you not giving funds to our arts and things that help our kids?’ ”
Sometimes lost in the discussion of medical marijuana is the extent to which it has become a small but growing source of new tax collections for cities and states that have been struggling to balance their budgets for more than four years now.
Colorado Springs collected more than $700,000 in taxes from the medical marijuana industry in 2011. It is not a lot of money for a big city. But given the harsh steps the city has taken in recent years — in 2010 it shut off a third of its streetlights to save $1.2 million — every bit helps.
Denver collected more than $3.4 million last year from sales tax and application and license fees, according to preliminary figures. The State of Colorado collected $5 million in sales tax from medical marijuana businesses last year, more than twice what it collected the year before.
Taxing marijuana is a relatively new field, and cities and states are taking different approaches to raising revenues.
Maine decided that medical marijuana should be subjected to the state’s 5 percent sales tax — unless the marijuana is baked into brownies. In that case, it is taxed at a higher 7 percent rate that the state levies on prepared foods.
Oregon closed a budget gap last year in part by raising the annual fees it charges people with doctors’ notes to join the state’s medical marijuana program. In October, the state doubled the fee to $200 a year — with reduced fees available to people on food stamps — to raise an estimated $6.7 million a year to pay for other health programs.
Of course, some of the money raised must be used to administer the medical marijuana programs and, in some cases, to increase regulation of the industry.
Budget planners always deal in uncertainties like whether tax revenues will rebound or how much it will really cost to provide services. But projecting medical marijuana revenues adds other layers of complications, including whether the federal government will shut down the dispensaries that state and local governments have decided to allow.
After signaling in 2009 that it would not normally pursue groups providing marijuana to sick patients, the Justice Department has cracked down on dispensaries in a number of states in recent months. The Internal Revenue Service has targeted a number of dispensaries that pay federal taxes as well, arguing that they are not entitled to the regular business deductions they have claimed because they should be considered drug trafficking organizations.
It has made life complicated for cities.
“What we do know is the federal government has made it complicated and the state government has made it complicated and it all flows downhill to us,” said Mayor Chuck Reed of San Jose, Calif., which collects about $2.5 million in taxes from the 100 marijuana dispensaries that have opened in the city.
Here in Oakland, medical marijuana is booming. Just a few blocks from City Hall is Oaksterdam University, which offers training for people in the industry with classes in state and federal law, civics, legal business structures and various “methods of ingestion.”
The biggest dispensary in the city by far, Harborside Health Center, has 104,000 customers and employs 120 people, 90 percent of whom are from Oakland, in well-paying jobs with good benefits.
Its executive director, Stephen DeAngelo, helped lead the movement several years ago to have the city tax the marijuana industry. “At that time, the city was talking about closing down some really beloved institutions,” he said, adding that Oakland’s fiscal plight led the center to think about ways of helping the city. “What better way of doing that than with a tax?”
But when the city tripled the tax rate to 5 percent in 2010, he worried. “I thought 5 percent was a bit excessive,” Mr. DeAngelo said, but he added that the center was able to absorb the costs. Now, he said, the center is among the biggest taxpayers in Oakland.
Oakland will probably not be able to double its tax collections by doubling the number of dispensaries. Mr. McPherson, the city tax administrator, said that in many cases the same pool of medical marijuana users would simply be choosing from more places. But opening a dispensary near the Berkeley border, he said, might capture some of the Oakland residents who currently go to a dispensary in Berkeley.
Mr. McPherson said the city stood to reap more of what he called the “secondary benefits.”
“You’ve got accountants that are working for them, you’ve got all the security companies that are working for them, you have labs that are working for them, you have bakeries that are baking all the edibles, you have union employees that are getting great benefits, you have delivery services, hydroponic stores, doctors get some benefit,” he said. “It’s the secondary market that gains from this, and all of those pay business taxes to us.”
Medical Marijuana Crackdown Gets Tighter
For medical marijuana advocates, it’s a backhanded slap in the face.
Despite earlier pronouncements showing tepid support for states’ medical marijuana laws, the Obama administration last year reversed its position. Since then the DEA has exponentially increased its “investigations” into dozens of dispensaries around the state.
Now, 12 of the remaining 21 medical marijuana dispensaries in the San Francisco area are being threatened.
The tactics used by the DEA, under other circumstances, would probably be considered unethical, even thuggish. The agency has made demands for private information not normally released, even though dispensaries are already inspected on a yearly basis by state officials.
They have even issued letters to landlords threatening prosecution and prison time if the dispensaries were not shut down.
Medical marijuana advocates are frustrated that the DEA and the U.S. attorneys are going after legal, compliant operations instead of focusing their attention on untaxed, illegal operations.
Still more aggravating is what advocates see as a lack of action on the part of The City to change that. Instead of the fighting against the crackdown, the city has largely cooperated with the DEA, suspending its permitting process last fall to prevent the opening of any new dispensaries.
And while the city’s Board of Supervisors passed a resolution in support medical marijuana last fall, they have not taken any action since.
“There a definite void in leadership here,” said state Assemblyman Tom Ammiano, D-San Francisco. Federal enforcement, he claims, is “undermining the will of [California] voters,” who voted to legalize marijuana for medical use way back in 1996.
Unfortunately, the outlook for dispensaries probably won’t improve anytime soon.
By Matthew Stensland-Bos
More at SFBay: http://sfbay.ca/2012/02/10/medical-marijuana-crackdown-gets-tighter/#ixzz1m19zbJ2h
ASA Files Federal Appeal in Bid to Reclassify Medical Cannabis
ASA Files Federal Appeal in Bid
|


